Roche

October 8, 2009

SurModics' Drug Delivery to Release Lucentis for Macular Degeneration

Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration.